Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

NCT05705401 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1300

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

RADIATION: Standard of Care Adjuvant Breast Radiation
DRUG: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation

Sponsor

NRG Oncology

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]